Iris Gomez

533 total citations
16 papers, 383 citations indexed

About

Iris Gomez is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Iris Gomez has authored 16 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Iris Gomez's work include Thyroid Cancer Diagnosis and Treatment (10 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Medical Imaging and Pathology Studies (4 papers). Iris Gomez is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (10 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Medical Imaging and Pathology Studies (4 papers). Iris Gomez collaborates with scholars based in Austria and United States. Iris Gomez's co-authors include E. Kresnik, Peter Mikosch, Peter Lind, Peter Lind, G. Kumnig, H. J. Gallowitsch, H. J. Gallowitsch, Isabel Igerc, H. Stettner and I. Igerc and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging, Surgery and Thyroid.

In The Last Decade

Iris Gomez

16 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Gomez Austria	9	300	174	138	78	59	16	383
A Arlandini Italy	10	204 0.7×	159 0.9×	61 0.4×	32 0.4×	62 1.1×	15	302
Marialaura Pesenti Italy	5	257 0.9×	209 1.2×	34 0.2×	40 0.5×	28 0.5×	6	305
Federico Arecco Italy	9	229 0.8×	108 0.6×	53 0.4×	42 0.5×	29 0.5×	10	321
B. Leisner Germany	10	232 0.8×	136 0.8×	92 0.7×	42 0.5×	38 0.6×	45	354
Federico Cappellacci Italy	10	160 0.5×	142 0.8×	39 0.3×	26 0.3×	24 0.4×	26	242
Ahmet Dirikoç Türkiye	10	293 1.0×	215 1.2×	37 0.3×	47 0.6×	12 0.2×	25	354
Leonardo D’Aloiso Italy	9	332 1.1×	229 1.3×	31 0.2×	63 0.8×	9 0.2×	12	385
Al Driedger Canada	5	241 0.8×	109 0.6×	141 1.0×	25 0.3×	26 0.4×	7	304
Tamás Solymosi Hungary	8	247 0.8×	168 1.0×	39 0.3×	30 0.4×	11 0.2×	18	305
Masud Haq United Kingdom	6	207 0.7×	108 0.6×	114 0.8×	18 0.2×	30 0.5×	8	279

Countries citing papers authored by Iris Gomez

Since Specialization

Citations

This map shows the geographic impact of Iris Gomez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Gomez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Gomez more than expected).

Fields of papers citing papers by Iris Gomez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Gomez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Gomez. The network helps show where Iris Gomez may publish in the future.

Co-authorship network of co-authors of Iris Gomez

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Gomez. A scholar is included among the top collaborators of Iris Gomez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Gomez. Iris Gomez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Zöller, Michael, Isabel Igerc, E. Kresnik, et al.. (2006). Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality?. European Journal of Nuclear Medicine and Molecular Imaging. 34(4). 487–495. 63 indexed citations

2.

Igerc, Isabel, et al.. (2006). Is There a Role for Sandostatin Treatment in Patients with Progressive Thyroid Cancer and Iodine-Negative But Somatostatin-Receptor–Positive Metastases?. Thyroid. 16(11). 1113–1119. 18 indexed citations

3.

Kresnik, E., H. J. Gallowitsch, Peter Mikosch, et al.. (2003). Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 133(3). 294–299. 112 indexed citations

4.

Lind, P., E. Kresnik, G. Kumnig, et al.. (2003). ¹⁸F‐FDG‐PET in the Follow‐up of Thyroid Cancer. PubMed. 30(1). 17–21. 25 indexed citations

5.

Heinisch, Martin, G. Kumnig, Peter Mikosch, et al.. (2002). Goiter Prevalence and Urinary Iodide Excretion in a Formerly Iodine-Deficient Region After Introduction of Statutory Iodization of Common Salt. Thyroid. 12(9). 809–814. 24 indexed citations

6.

Gomez, Iris, et al.. (2000). Scintigraphic and Ultrasonographic Appearance in Different Tumor Stages of Thyroid Carcinoma. 27(1). 32–35. 3 indexed citations

7.

Kresnik, E., H J Gallowitsch, Peter Mikosch, et al.. (2000). Scintigraphic and Ultrasonographic Appearance in Different Tumor Stages of Thyroid Carcinoma. PubMed. 27(1). 32–35. 5 indexed citations

8.

Kresnik, E., H. J. Gallowitsch, Peter Mikosch, et al.. (1999). Immunoscintigraphy of an Inflammatory Process in Crohn's Disease With a Technetium-99m-Labeled Fragment (MN3 Fab′) and With an Intact Monoclonal Anti-granulocyte Antibody (Mab BW 250/183). Clinical Nuclear Medicine. 24(1). 64–65. 5 indexed citations

9.

Gallowitsch, H. J., Peter Mikosch, E. Kresnik, et al.. (1998). Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.. PubMed. 39(5). 870–5. 32 indexed citations

10.

Mikosch, Peter, et al.. (1997). Technetium-99m-tetrofosmin uptake in sarcoidosis stage I.. PubMed. 38(11). 1786–7. 2 indexed citations

11.

Mikosch, Peter, et al.. (1997). Technetium 99m Tetrofosmin Parathyroid Imaging. Investigative Radiology. 32(8). 459–465. 29 indexed citations

12.

Kresnik, E., et al.. (1997). Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 716–721. 16 indexed citations

13.

Lind, Peter, et al.. (1997). Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.. PubMed. 38(3). 348–52. 44 indexed citations

14.

Kresnik, E., et al.. (1997). Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. 24(7). 716–721. 1 indexed citations

15.

Lind, Peter, H. J. Gallowitsch, Peter Mikosch, et al.. (1997). Radioimmunoscintigraphy With Tc-99m Labeled Monoclonal Antibody 170H.82 in Suspected Primary, Recurrent, or Metastatic Breast Cancer. Clinical Nuclear Medicine. 22(1). 30–34. 3 indexed citations

16.

Gomez, Iris. (1993). The Consequences of Nonappearance: Interpreting New Section 242B of the Immigration and Nationality Act. San Diego law review. 30(1). 75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact